Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...
The FDA has elevated a recall of Inspire Medical’s nerve-stimulating implant for the treatment of obstructive sleep apnea. The agency handed down a Class I recall designation to the effort, its most ...
Inspire Medical Systems, Inc. rebounded 40% from August lows after higher reimbursements, as it sounds more upbeat on the ...
Shares of Inspire Medical Systems (INSP) are up ~28% in Monday trading after CMS dramatically boosted 2026 reimbursement ...
Inspire Medical Systems INSP recently unveiled promising clinical data from its Inspire V system at the ISSS and AAO-HNS meetings, showcasing strong safety, enhanced respiratory sensing and improved ...
Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 3.9% in the afternoon session after the company published promising clinical data for its next-generation Inspire V ...
MUSKEGON, Mich. — About 30 million people in the United States deal with sleep apnea. Of those, only about 6 million are even diagnosed. Disruptive sleep can affect mental clarity, put a strain on ...
For people with sleep apnea who have trouble using a continuous positive airway pressure machine, there is hope for a good night's sleep. There is a new sleep apnea treatment available, but it does ...
If a traditional CPAP machine isn't for you, you might consider the Inspire sleep apnea device as an alternative treatment option. Here's what you need to know. Taylor Leamey wrote about all things ...
The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results